Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-38.37	41.32	67.06
Graham Fair Price	8.03	14.86	13.75
PEG	108.90	1.64	-0.78
Price/Book	-10.27	1.89	2.10
Price/Cash Flow	86.27	-25.61	-186.59
Prices/Earnings	-25.15	28.94	38.66
Price/Sales	-4.98	2.37	2.49
Price/FCF	86.27	-25.61	-186.59
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.09	0.11	0.11
Operating Margin	-39.32	0.01	0.02
ROA	12.91	< 0.005	< 0.005
ROE	0.01	0.02	19.88
ROIC	0.01	< 0.005	-48.03
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	< 0.005	263.93
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.55	-0.43	20.52
EPS QOQ	-0.49	0.18	-64.17
FCF QOQ	-1.12	-5.45	-386.01
Revenue QOQ	-0.06	-0.07	-7.16
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	69.97	81.99	17.17
Days Sales Outstanding (DSO)	80.20	90.89	13.34
Inventory Turnover	1.29	1.10	-14.66
Debt/Capitalization	0.15	0.17	13.51
Quick Ratio	1.04	0.93	-10.94
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	24.86	24.53	-1.34
Cash	18.50	16.60	-10.28
Capex	0.05	-0.96	1817.52
Free Cash Flow	-0.28	-1.81	-544.98
Revenue	21.01	19.57	-6.83
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.47	1.37	-6.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-18.12	-11.12	38.67
Naive Interpretation	Member

06 - Financial Health · Weak

Rating